Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma

M. Frontiera, J. L. Murray, L. Lamki, J. Thomas, W. Satterlee, R. Schmelter, M. G. Rosenblum, M. B. Khazaeli, M. W. Unger, W. A. Robinson, P. A. Bunn

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences